We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
(-5.9%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$25.4M |
| 2 |
AbbVie
ABBV
|
+$21.9M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$19.2M |
| 4 |
Waste Management
WM
|
+$19M |
| 5 |
Gilead Sciences
GILD
|
+$17.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$70.2M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
+$45.8M |
| 3 |
Biogen
BIIB
|
+$43.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.8M |
| 5 |
Amgen
AMGN
|
+$21.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.81% |
| 2 | Technology | 18.27% |
| 3 | Financials | 10.05% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Service Corp International
SCI
$11.4B
| $694K | 0.01% |
14,508
-23,057
| -61% | -$1.08M |
|
627
Teck Resources
TECK
$29.3B
| $693K | 0.01% |
42,745
-1,196
| -3% | -$22.6K |
|
628
KB Financial Group
KB
$41.5B
| $690K | 0.01% |
19,318
-1,781
| -8% | -$62.7K |
|
629
Quanterix
QTRX
$173M
| $681K | 0.01% |
31,000
+7,000
| +29% | +$195K |
|
|
BLD
630
DELISTED
TopBuild
BLD
| $680K | 0.01% |
7,052
+700
| +11% | +$61.8K |
|
|
XENT
631
DELISTED
Intersect ENT, Inc
XENT
| $680K | 0.01% |
40,000
| – | – |
|
632
DXC Technology
DXC
$1.68B
| $676K | 0.01% |
22,910
-4,267
| -16% | -$182K |
|
633
Dell
DELL
$276B
| $656K | 0.01% |
24,962
-983
| -4% | -$26.1K |
|
634
POSCO
PKX
$16.1B
| $656K | 0.01% |
+13,919
| New | +$653K |
|
635
Guardant Health
GH
$19.3B
| $651K | 0.01% |
10,200
-4,590
| -31% | -$404K |
|
636
Snap
SNAP
$7.6B
| $642K | 0.01% |
+40,604
| New | +$650K |
|
637
Magna International
MGA
$18.3B
| $632K | 0.01% |
11,855
-17,099
| -59% | -$852K |
|
638
Huntington Ingalls Industries
HII
$11.4B
| $631K | 0.01% |
2,980
+482
| +19% | +$105K |
|
639
National Fuel Gas
NFG
$7.67B
| $629K | 0.01% |
13,396
-73,920
| -85% | -$3.59M |
|
640
Tapestry
TPR
$29.8B
| $629K | 0.01% |
24,160
| – | – |
|
641
Shopify
SHOP
$165B
| $618K | 0.01% |
19,830
+5,970
| +43% | +$204K |
|
|
CTRA
642
DELISTED
Coterra Energy
CTRA
| $617K | 0.01% |
35,109
+6,015
| +21% | +$115K |
|
643
Fox Class B
FOX
$21.3B
| $612K | 0.01% |
19,417
+3,259
| +20% | +$113K |
|
644
Newell Brands
NWL
$2.2B
| $612K | 0.01% |
32,704
+3,566
| +12% | +$57.5K |
|
645
Tetra Tech
TTEK
$8.28B
| $595K | 0.01% |
+34,310
| New | +$561K |
|
|
DISH
646
DELISTED
DISH Network Corp.
DISH
| $594K | 0.01% |
17,429
+3,437
| +25% | +$123K |
|
647
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $592K | 0.01% |
+1,106
| New | +$327K |
|
648
Albemarle
ALB
$13.7B
| $591K | 0.01% |
8,495
-2,657
| -24% | -$181K |
|
649
SolarEdge
SEDG
$2.62B
| $583K | 0.01% |
6,964
-5,536
| -44% | -$413K |
|
650
Cemex
CX
$17.6B
| $566K | 0.01% |
144,375
| – | – |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2019 Portfolio in Review
As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.
- Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
- Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
- Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
- Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
- Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
- Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
- Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.
Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.